{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/achieving-sponsor-goals-efficient-end-end-solutions#webpage",
"url": "https://www.fortrea.com/insights/achieving-sponsor-goals-efficient-end-end-solutions",
"name": "Achieving sponsor goals with efficient end-to-end solutions",
"description": "This Fortrea info sheet highlights specialized capabilities supporting cell and gene therapy clinical development across advanced therapeutic and precision medicine programs. The publication discusses operational support for cell therapy and gene therapy clinical trials, including patient recruitment strategy, global clinical trial management, regulatory support, biospecimen logistics, supply chain coordination, and advanced therapy operational planning. The publication also highlights challenges associated with cell and gene therapy development, including complex manufacturing workflows, time-sensitive logistics, cold-chain management, specialized site coordination, and operational scalability across global clinical trial activities. Fortrea supports sponsors through integrated clinical development services designed to strengthen continuity across early-phase and late-phase advanced therapy programs while supporting operational efficiency throughout the clinical trial lifecycle. By integrating specialized operational support with regulatory strategy and global trial management, Fortrea supports evolving cell and gene therapy clinical development programs and emerging precision medicine research activities."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Achieving sponsor goals with efficient end-to-end solutions",
"item": "https://www.fortrea.com/insights/achieving-sponsor-goals-efficient-end-end-solutions"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/achieving-sponsor-goals-efficient-end-end-solutions#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/achieving-sponsor-goals-efficient-end-end-solutions#webpage"
},
"headline": "Achieving sponsor goals with efficient end-to-end solutions",
"description": "This Fortrea info sheet highlights specialized capabilities supporting cell and gene therapy clinical development across advanced therapeutic and precision medicine programs. The publication discusses operational support for cell therapy and gene therapy clinical trials, including patient recruitment strategy, global clinical trial management, regulatory support, biospecimen logistics, supply chain coordination, and advanced therapy operational planning. The publication also highlights challenges associated with cell and gene therapy development, including complex manufacturing workflows, time-sensitive logistics, cold-chain management, specialized site coordination, and operational scalability across global clinical trial activities. Fortrea supports sponsors through integrated clinical development services designed to strengthen continuity across early-phase and late-phase advanced therapy programs while supporting operational efficiency throughout the clinical trial lifecycle. By integrating specialized operational support with regulatory strategy and global trial management, Fortrea supports evolving cell and gene therapy clinical development programs and emerging precision medicine research activities.",
"genre": "Info Sheet",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-02/achieving-sponsor-goals-with-efficient-end-to-end-solutions.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-02-21",
"dateModified": "2025-02-21",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-02/achieving-sponsor-goals-with-efficient-end-to-end-solutions.pdf",
"encodingFormat": "application/pdf"
}
}
]
}